Newswriter.ai

Curated Business & Technology News from Around the Internet

Bank of America Downgrades Novavax to Underperform, Citing Long-Term Growth Concerns FEATURED

Bank of America Downgrades Novavax to Underperform, Citing Long-Term Growth Concerns

Bank of America downgraded Novavax to Underperform and reduced its price target to $7, highlighting concerns about the company's ability to sustain growth amid shifting vaccine demand and stricter FDA …
Source August 20, 2025
Read More

Showing 28 of 4036 articles (Page 101 of 145)